Treatment-related AEs (N = 31)
| AEs . | n (%) . |
|---|---|
| Any grade (≥2 patients) | |
| Any | 22 (71) |
| Diarrhea | 7 (23) |
| Hypothyroidism | 4 (13) |
| Nausea | 4 (13) |
| Pneumonitis | 4 (13) |
| Dyspnea | 3 (10) |
| Fatigue | 3 (10) |
| Abdominal distension | 2 (6) |
| Arthralgia | 2 (6) |
| Increased aspartate aminotransferase level | 2 (6) |
| Asthenia | 2 (6) |
| Increased blood creatine phosphokinase level | 2 (6) |
| Chills | 2 (6) |
| Decreased appetite | 2 (6) |
| Hypertriglyceridemia | 2 (6) |
| Thyroiditis | 2 (6) |
| Vomiting | 2 (6) |
| Increased weight | 2 (6) |
| Xerosis | 2 (6) |
| Grade 3 | |
| Any | 6 (19) |
| Colitis | 1 (3) |
| Axillary pain | 1 (3) |
| Increased aspartate aminotransferase level | 1 (3) |
| Back pain | 1 (3) |
| Joint swelling | 1 (3) |
| Nephrotic syndrome | 1 (3) |
| Dyspnea | 1 (3) |
| AEs . | n (%) . |
|---|---|
| Any grade (≥2 patients) | |
| Any | 22 (71) |
| Diarrhea | 7 (23) |
| Hypothyroidism | 4 (13) |
| Nausea | 4 (13) |
| Pneumonitis | 4 (13) |
| Dyspnea | 3 (10) |
| Fatigue | 3 (10) |
| Abdominal distension | 2 (6) |
| Arthralgia | 2 (6) |
| Increased aspartate aminotransferase level | 2 (6) |
| Asthenia | 2 (6) |
| Increased blood creatine phosphokinase level | 2 (6) |
| Chills | 2 (6) |
| Decreased appetite | 2 (6) |
| Hypertriglyceridemia | 2 (6) |
| Thyroiditis | 2 (6) |
| Vomiting | 2 (6) |
| Increased weight | 2 (6) |
| Xerosis | 2 (6) |
| Grade 3 | |
| Any | 6 (19) |
| Colitis | 1 (3) |
| Axillary pain | 1 (3) |
| Increased aspartate aminotransferase level | 1 (3) |
| Back pain | 1 (3) |
| Joint swelling | 1 (3) |
| Nephrotic syndrome | 1 (3) |
| Dyspnea | 1 (3) |
There were no grade 4 or 5 treatment-related AEs.